{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T01:22:12Z","timestamp":1755998532480},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Nephrotic syndrome (NS) results in massive proteinuria and hypoalbuminemia, which are responsible for a compensatory increase in protein synthesis in the liver. Serum cholinesterase (ChE) also increases in NS. However, its clinical value is not fully elucidated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, 184 patients with NS who underwent kidney biopsy were included. The patients were divided into two groups according to serum ChE levels, as follows: hypercholinesterasemia (HC) and non-hypercholinesterasemia (NHC) groups. The clinical factors were compared between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The HC group had significantly more severe proteinuria and higher prevalence of high selective proteinuria than the NHC group. Furthermore, the prevalence of minimal change nephrotic syndrome (MCNS) was significantly higher in the HC group than that in the NHC group. Multivariate analysis revealed that the severity of proteinuria and MCNS were significantly associated with HC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this study, HC in NS was associated with the severity of proteinuria and MCNS, and could help clinicians predict the histological diagnosis of NS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02764-0","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:02:27Z","timestamp":1648922547000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical value of serum cholinesterase levels in Nephrotic syndrome: an observational study"],"prefix":"10.1186","volume":"23","author":[{"given":"Kimihiko","family":"Goto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,2]]},"reference":[{"key":"2764_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10157-015-1216-x","volume":"20","author":"S Nishi","year":"2016","unstructured":"Nishi S, Ubara Y, Utsunomiya Y, et al. Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin Exp Nephrol. 2016;20:342\u201370.","journal-title":"Clin Exp Nephrol"},{"key":"2764_CR2","first-page":"479","volume":"93","author":"C Kodner","year":"2016","unstructured":"Kodner C. Diagnosis and management of nephrotic syndrome in adults. Am Fam Physician. 2016;93:479\u201385.","journal-title":"Am Fam Physician"},{"key":"2764_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","volume":"90","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int. 2016;90:41\u201352.","journal-title":"Kidney Int"},{"key":"2764_CR4","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/clinchem\/43.7.1223","volume":"43","author":"J Joven","year":"1997","unstructured":"Joven J, Cliville X, Camps J, et al. Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosity. Clin Chem. 1997;43:1223\u201331.","journal-title":"Clin Chem"},{"key":"2764_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2215\/CJN.10131011","volume":"7","author":"BA Kerlin","year":"2012","unstructured":"Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol. 2012;7:513\u201320.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2764_CR6","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1681\/ASN.2014111097","volume":"26","author":"BA Kerlin","year":"2015","unstructured":"Kerlin BA, Waller AP, Sharma R, et al. Disease severity correlates with thrombotic capacity in experimental Nephrotic syndrome. J Am Soc Nephrol. 2015;26:3009\u201319.","journal-title":"J Am Soc Nephrol"},{"key":"2764_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ki.1992.17","volume":"41","author":"PE Ballmer","year":"1992","unstructured":"Ballmer PE, Weber BK, Roy-Chaudhury P, et al. Elevation of albumin synthesis rates in nephrotic patients measured with [1-13C] leucine. Kidney Int. 1992;41:132\u20138.","journal-title":"Kidney Int"},{"key":"2764_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1046\/j.1523-1755.1999.00562.x","volume":"56","author":"J Kang","year":"1999","unstructured":"Kang J, Holland M, Jones H, Kaysen GA. Coordinate augmentation in expression of genes encoding transcription factors and liver secretory proteins in hypo-oncotic states. Kidney Int. 1999;56:452\u201360.","journal-title":"Kidney Int"},{"key":"2764_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","volume":"148","author":"O Lockridge","year":"2015","unstructured":"Lockridge O. Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther. 2015;148:34\u201346.","journal-title":"Pharmacol Ther"},{"key":"2764_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3892\/br.2013.60","volume":"1","author":"F Meng","year":"2013","unstructured":"Meng F, Yin X, Ma X, et al. Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients. Biomed Rep. 2013;1:265\u20138.","journal-title":"Biomed Rep"},{"key":"2764_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13539-012-0083-5","volume":"4","author":"L Santarpia","year":"2013","unstructured":"Santarpia L, Grandone I, Contaldo F, Pasanisi F. Butyrylcholinesterase as a prognostic marker: a review of the literature. J Cachexia Sarcopenia Muscle. 2013;4:31\u20139.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"2764_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0002-9343(53)90390-8","volume":"14","author":"LJ Vorhaus","year":"1953","unstructured":"Vorhaus LJ, Kark RM. Serum cholinesterase in health and disease. Am J Med. 1953;14(6):707\u201319.","journal-title":"Am J Med"},{"key":"2764_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(66)92539-6","volume":"2","author":"JS Cameron","year":"1966","unstructured":"Cameron JS, Blandford G. The simple assessment of selectivity in heavy proteinuria. Lancet. 1966;2:242\u20137.","journal-title":"Lancet"},{"key":"2764_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0009-9120(75)91072-3","volume":"8","author":"RC Way","year":"1975","unstructured":"Way RC, Hutton CJ, Kutty KM. Relationship between serum cholinesterase and low density lipoproteins in children with nephrotic syndrome. Clin Biochem. 1975;8:103\u20137.","journal-title":"Clin Biochem"},{"issue":"2 Pt 1","key":"2764_CR15","doi-asserted-by":"publisher","first-page":"C397","DOI":"10.1152\/ajpcell.1992.263.2.C397","volume":"263","author":"A Yamauchi","year":"1992","unstructured":"Yamauchi A, Fukuhara Y, Yamamoto S, et al. Oncotic pressure regulates gene transcriptions of albumin and apolipoprotein B in cultured rat hepatoma cells. Am J Phys. 1992;263(2 Pt 1):C397\u2013404.","journal-title":"Am J Phys"},{"key":"2764_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/IJGM.S102819","volume":"9","author":"DG Levitt","year":"2016","unstructured":"Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229\u201355.","journal-title":"Int J Gen Med"},{"key":"2764_CR17","doi-asserted-by":"publisher","unstructured":"Tojo A. Mechanism underlying selective albuminuria in minimal change Nephrotic syndrome. Int J Nephrol. 2019;5859102. https:\/\/doi.org\/10.1155\/2019\/5859102.","DOI":"10.1155\/2019\/5859102"},{"key":"2764_CR18","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2215\/CJN.01920219","volume":"14","author":"SM Korbet","year":"2019","unstructured":"Korbet SM, Whittier WL. Management of adult minimal change disease. Clin J Am Soc Nephrol. 2019;14:911\u20133.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2764_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ki.2012.180","volume":"82","author":"EC Siddall","year":"2012","unstructured":"Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82(6):635\u201342.","journal-title":"Kidney Int"},{"issue":"Suppl 6","key":"2764_CR20","first-page":"vi30","volume":"18","author":"HA Koomans","year":"2003","unstructured":"Koomans HA. Pathophysiology of oedema in idiopathic nephrotic syndrome. Nephrol Dial Transplant. 2003;18(Suppl 6):vi30\u20132.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02764-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:03:41Z","timestamp":1648922621000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02764-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2764"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02764-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,2]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our protocols were approved by the Kobe University Clinical Research Ethical Committee (no. B190327) and performed according to the recommendations of the Declaration of Helsinki for Biomedical Research involving human subjects. The Kobe University Clinical Research Ethical Committee approved to waive off the need for an informed consent and to use the opt-out approach in the study, because the data were retrospectively and anonymously analyzed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}